HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
C. Belizna(Centre National de la Recherche Scientifique), Laurent Loufrani(Centre National de la Recherche Scientifique), Aleksandra Djoković(University of Belgrade), Şule Apraş Bilgen(Hacettepe University), Valentina Canti(Vita-Salute San Raffaele University), Pascale Jeannin(Centre National de la Recherche Scientifique), Thomas Le Gallou(Centre Hospitalier Universitaire de Rennes), José Omar Latino(El Hospital General de Agudos Carlos G. Durand), Patrick Blanco(Centre National de la Recherche Scientifique), Noémie Jourde‐Chiche(Hôpital de la Conception), Francesca Pregnolato(IRCCS Istituto Auxologico Italiano), Karina de Leeuw(University Medical Center Groningen), Enrique Esteve‐Valverde(Althaia), Teresa Delross(University of Padua), Emmanuel Andrès(Hôpitaux Universitaires de Strasbourg), Milena Hasan(Institut Pasteur), P. Jégo(Centre Hospitalier Universitaire de Rennes), Achile Aouba(Université de Caen Normandie), C. Landron(Université de Poitiers), Howard Amital(Tel Aviv University), Levent Kılıç(Hacettepe University), Raquel Ferrer‐Oliveras(Vall d'Hebron Hospital Universitari), Laura Damian(Babeș-Bolyai University), Céline Fassot(Centre National de la Recherche Scientifique), J. Kh. Khizroeva(Sechenov University), Laura Andréoli(University of Brescia), Boris Bienvenu(Hôpital Saint Joseph), M. Hamidou(Centre Hospitalier Universitaire de Nantes), B. Imbert(Centre Hospitalier Universitaire de Grenoble), Jaume Alijotas‐Reig(Universitat Autònoma de Barcelona), Alban Godon(Centre Hospitalier Universitaire d'Angers), Emmanuelle Dernis(Centre Hospitalier du Mans), Katrien Devreese(Ghent University Hospital), Estibaliz Lazaro(Centre National de la Recherche Scientifique), María Orietta Borghi(IRCCS Istituto Auxologico Italiano), S. Abad(Université Sorbonne Paris Nord), Laurent Arnaud(Inserm), J Chrétien(Centre Hospitalier Universitaire d'Angers), Maarten Limper(University Medical Center Utrecht), Elisabeta Candrea(Iuliu Hațieganu University of Medicine and Pharmacy), Daniel Henrion(Centre National de la Recherche Scientifique), Miri Blank(Tel Aviv University), Laurent Chiche(Hôpital Européen), Zahir Amoura(Sorbonne Université), Olivier Lambotte(Université Paris-Sud), Viktoria Bitsadze(Sechenov University), Maria Favarò(University of Padua), Antonia Caligaro(University of Padua), P Jeandel(Université Côte d'Azur), Jan Willem Cohen Tervaert(University of Alberta)
Cited by 76
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355
2021 DORIS definition of remission in SLE: final recommendations from an international task force
|Lupus Science & Medicine|2021|340
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316